HighLife’s TMVR System Gains CE Mark Approval, Opening New Pathways for Severe Mitral Regurgitation Treatment in Europe
HighLife's innovative transcatheter mitral valve replacement system has secured CE Mark approval, enabling European commercialization for high-risk adult patients with…
